Literature DB >> 17601388

The clinical assessment of retinal microvascular structure and therapeutic implications.

Alun D Hughes1.   

Abstract

Examination of the retinal microvasculature is widely used to assess diabetic eye disease and as an indicator of target organ damage in hypertension. The diagnostic value of grading of hypertensive retinopathy is dubious; however, many recent studies have demonstrated that hypertensive retinopathy is associated with a range of risk factors for cardiovascular disease and may predict cardiovascular events independently of blood pressure. Developments in digital imaging and computer-assisted analysis have facilitated the quantitative assessment of microvascular changes in cardiovascular disease. These approaches may be useful for assessing cardiovascular risk and targeting therapeutic intervention.

Entities:  

Year:  2007        PMID: 17601388     DOI: 10.1007/s11936-007-0018-1

Source DB:  PubMed          Journal:  Curr Treat Options Cardiovasc Med        ISSN: 1092-8464


  62 in total

1.  Computer-assisted measurement of retinal vessel diameters in the Beaver Dam Eye Study: methodology, correlation between eyes, and effect of refractive errors.

Authors:  Tien Yin Wong; Michael D Knudtson; Ronald Klein; Barbara E K Klein; Stacy M Meuer; Larry D Hubbard
Journal:  Ophthalmology       Date:  2004-06       Impact factor: 12.079

Review 2.  Ocular and systemic causes of retinopathy in patients without diabetes mellitus.

Authors:  Jayant Venkatramani; Paul Mitchell
Journal:  BMJ       Date:  2004-03-13

Review 3.  Hypertensive retinopathy.

Authors:  Tien Y Wong; Paul Mitchell
Journal:  N Engl J Med       Date:  2004-11-25       Impact factor: 91.245

Review 4.  Retinal vascular image analysis as a potential screening tool for cerebrovascular disease: a rationale based on homology between cerebral and retinal microvasculatures.

Authors:  Niall Patton; Tariq Aslam; Thomas Macgillivray; Alison Pattie; Ian J Deary; Baljean Dhillon
Journal:  J Anat       Date:  2005-04       Impact factor: 2.610

5.  The regional distribution of diabetic retinopathy lesions may reflect risk factors for progression of the disease.

Authors:  T Bek; A Helgesen
Journal:  Acta Ophthalmol Scand       Date:  2001-10

6.  Direct measurement of retinal vessel diameter: comparison with microdensitometric methods based on fundus photographs.

Authors:  Y Suzuki
Journal:  Surv Ophthalmol       Date:  1995-05       Impact factor: 6.048

7.  Accurate vessel width measurement from fundus photographs: a new concept.

Authors:  S M Rassam; V Patel; O Brinchmann-Hansen; O Engvold; E M Kohner
Journal:  Br J Ophthalmol       Date:  1994-01       Impact factor: 4.638

8.  The relation of systemic hypertension to changes in the retinal vasculature: the Beaver Dam Eye Study.

Authors:  R Klein; B E Klein; S E Moss
Journal:  Trans Am Ophthalmol Soc       Date:  1997

9.  Retinal vascular network architecture in low-birth-weight men.

Authors:  N Chapman; A Mohamudally; A Cerutti; A Stanton; A A Sayer; C Cooper; D Barker; A Rauf; J Evans; R Wormald; P Sever; A Hughes; S Thom
Journal:  J Hypertens       Date:  1997-12       Impact factor: 4.844

10.  The relation of retinal vessel caliber to the incidence and progression of diabetic retinopathy: XIX: the Wisconsin Epidemiologic Study of Diabetic Retinopathy.

Authors:  Ronald Klein; Barbara E K Klein; Scot E Moss; Tien Y Wong; Larry Hubbard; Karen J Cruickshanks; Mari Palta
Journal:  Arch Ophthalmol       Date:  2004-01
View more
  2 in total

1.  Determinants of retinal microvascular architecture in normal subjects.

Authors:  Alun D Hughes; Tien Y Wong; Nicholas Witt; Richard Evans; Simon A Mcg Thom; Barbara E Klein; Nish Chaturvedi; Ronald Klein
Journal:  Microcirculation       Date:  2009-02       Impact factor: 2.628

2.  The Association of Type 2 Diabetes Mellitus with Cerebral Gray Matter Volume Is Independent of Retinal Vascular Architecture and Retinopathy.

Authors:  C Moran; R J Tapp; A D Hughes; C G Magnussen; L Blizzard; T G Phan; R Beare; N Witt; A Venn; G Münch; B C Amaratunge; V Srikanth
Journal:  J Diabetes Res       Date:  2016-05-25       Impact factor: 4.011

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.